Form 4: BioLife Solutions CFO Sells Shares for Tax Obligations

BioLife Solutions CFO Troy Wichterman sold 590 shares of common stock for tax obligations under a pre-arranged 10b5-1 plan.

Summary

• Troy Wichterman, Chief Financial Officer of BioLife Solutions Inc. (BLFS), reported a sale of company common stock.
• The transaction involved the disposition of 590 shares at a price of $25.44 per share.
• Following this transaction, Mr. Wichterman directly owns 185,218 shares of BioLife Solutions common stock.
• The sale was executed on August 26, 2025, as part of a Rule 10b5-1(c) trading plan established on February 24, 2022.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 6

Explanation: The sale of shares by the CFO is for tax withholding obligations under a pre-established 10b5-1 plan, which is a routine event and not indicative of a change in management's confidence in the company's future.

Positives

• The sale was pre-planned under a Rule 10b5-1(c) trading plan, indicating it was not a discretionary sale based on new, non-public information.
• The sale was for tax withholding obligations, a common reason for insider sales and not necessarily indicative of a negative outlook on the company.

Negatives

• An insider sale, even for tax purposes, reduces the direct ownership stake of a key executive.

Future Outlook

NA

Management Comments

• The sale was made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person effective as of February 24, 2022, to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Industry Context

NA

Comparison to Industry Standards

• The sale for tax withholding under a 10b5-1 plan is a common and standard practice among executives receiving equity compensation across various industries.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but the reason (tax withholding) mitigates concerns about management's confidence.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

The filing details a routine insider stock sale by the CFO for tax withholding purposes under a pre-established 10b5-1 plan. This type of transaction is common for executives receiving equity compensation and does not typically signal a change in the company's fundamental outlook or warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as this specific filing provides no new information to alter an existing investment decision.

Keywords

BioLife Solutions, BLFS, Troy Wichterman, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Tax Withholding, Restricted Stock